EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Symptom Clustering and Its Association with Treatment and Comorbidities in Advanced Head and Neck Cancer Patients: A Data-Driven Analysis

Symptom-Cluster und ihr Zusammenhang mit Behandlung und Komorbiditäten bei Patient:innen mit fortgeschrittenem Kopf-Hals-Krebs: datengetriebene Analyse

Chaitanya R. Patil, Nilesh A. Dhamne, Yogesh S. Anap, Parag J. Watve, Prasad T. Tanawade

Indian Journal of Medical and Paediatric Oncology · 23.09.2025

DOI: 10.1055/s-0045-1812017 ↗

Auf einen Blick

Bei 400 Patient:innen mit fortgeschrittenem Kopf-Hals-Krebs wurden 5 Symptom-Cluster identifiziert. Radiotherapie sowie Diabetes und Hypertonie waren mit stärkerer Symptomatik verbunden.

Fragestellung

Welche Symptom-Cluster treten bei Patient:innen mit fortgeschrittenem Kopf-Hals-Krebs auf, und wie sind sie mit Behandlung und Komorbiditäten assoziiert?

Methode

Prospektive Beobachtungsstudie von August 2021 bis August 2024; Erfassung von Symptomen mit der Edmonston Symptom Scale; Analyse mit explorativer Faktoranalyse, K-Means und hierarchischem Clustering.

Ergebnisse

5 Cluster: hohe Symptomlast; Schmerzen/Schluckstörungen; Übelkeit/Angst; Fatigue/Schluckstörungen; Gewichtsverlust/schwere Dysphagie. Radiotherapie war mit Dysphagie- und Gewichtsverlust-Clustern assoziiert.

Schlussfolgerung der Autor:innen

Die Autor:innen betonen den klinischen Wert der Erkennung von Symptom-Cluster. Die Zusammenhänge mit Radiotherapie und Komorbiditäten sprechen für angepasste Symptommanagement-Strategien.

Kernaussagen

  • 5 Symptom-Cluster wurden bei fortgeschrittenem HNC identifiziert
  • Radiotherapie war mit Dysphagie- und Gewichtsverlust-Clustern verbunden
  • Diabetes und Hypertonie waren mit höherer Symptomschwere assoziiert

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Medical and Paediatric Oncology, erschienen am 23.09.2025. Verfasst von Chaitanya R. Patil und 4 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

Auf einen BlickAbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Head and neck cancers (HNCs) are frequently associated with a complex symptom burden caused by both the disease and its treatment modalities, including surgery, radiotherapy, and chemotherapy. These symptoms often appear in clusters rather than as isolated events, considerably impairing patients' quality of life. Identifying these symptom clusters and understanding their relationships with treatment types and comorbidities is crucial for improving targeted symptom management. The aim of this study was to identify symptom clusters in patients with advanced HNC and evaluate their associations with treatment modalities and coexisting health conditions. A prospective observational study was conducted at the Department of Palliative Care, Kolhapur Cancer Center, from August 2021 to August 2024. A total of 400 patients with HNC undergoing chemotherapy, radiotherapy, or both were included. Symptom data were collected using the Edmonston Symptom Scale, evaluating pain, fatigue, nausea, depression, anxiety, anorexia, weight loss, dysphagia, and voice changes. Patient demographics, treatment details, and comorbidities (diabetes, hypertension, and ischemic heart disease) were recorded. Statistical analyses included exploratory factor analysis, K-means, and hierarchical clustering to identify symptom patterns. Associations were analyzed using ANOVA and chi-square tests. Five distinct symptom clusters were identified: (1) high symptom burden, (2) pain and swallowing difficulties, (3) nausea and anxiety dominant, (4) fatigue with swallowing issues, and (5) weight loss with severe dysphagia. Radiotherapy was significantly associated with clusters involving dysphagia and weight loss (p < 0.0001). Diabetes (p = 0.0010) and hypertension (p < 0.0001) were also significantly related to increased symptom severity. Chemotherapy showed no significant association with symptom clustering. Hierarchical clustering and principal component analysis confirmed the consistency of these patterns. The study emphasizes the clinical value of recognizing symptom clusters in patients with HNC. Significant associations with radiotherapy and comorbid conditions suggest the need for tailored symptom management strategies. Future research should focus on longitudinal tracking and the integration of machine learning techniques to further refine symptom classification and personalize care.

Zitieren

APA

Patil, C. R., Dhamne, N. A., Anap, Y. S., Watve, P. J., & Tanawade, P. T. (2025). Symptom Clustering and Its Association with Treatment and Comorbidities in Advanced Head and Neck Cancer Patients: A Data-Driven Analysis. Indian Journal of Medical and Paediatric Oncology. https://doi.org/10.1055/s-0045-1812017

Vancouver

Patil CR, Dhamne NA, Anap YS, Watve PJ, Tanawade PT. Symptom Clustering and Its Association with Treatment and Comorbidities in Advanced Head and Neck Cancer Patients: A Data-Driven Analysis. Indian Journal of Medical and Paediatric Oncology. 2025. doi:10.1055/s-0045-1812017

BibTeX
@article{Patil2025,
  author = {Patil, Chaitanya R. and Dhamne, Nilesh A. and Anap, Yogesh S. and Watve, Parag J. and Tanawade, Prasad T.},
  title = {Symptom Clustering and Its Association with Treatment and Comorbidities in Advanced Head and Neck Cancer Patients: A Data-Driven Analysis},
  journal = {Indian Journal of Medical and Paediatric Oncology},
  year = {2025},
  doi = {10.1055/s-0045-1812017}
}
Kostenlos starten →